Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2025-12-25 @ 12:03 PM
NCT ID:
NCT00278161
Group ID:
EG000
Title:
R-HiCy
Description:
Rituximab (R) and high-dose cyclophosphamide (HiCy) with pegfilgrastim support.
Pegfilgrastim: 6 mg SQ 24-48 hours after last dose of cyclophosphamide.
Rituximab: 375 mg/m\^2/day on Days 1, 4, 8, 11, 45, and 52.
Cyclophosphamide: 50 mg/kg/day on Days 15, 16, 17, and 18.
Deaths Number Affected:
11
Deaths Number At Risk:
None
Serious Number Affected:
15
Serious Number At Risk:
81
Other Number Affected:
64
Other Number At Risk:
81
Study:
NCT00278161
Results Section:
NCT00278161
Adverse Events Module:
NCT00278161